Summary of events and transition probabilities
| From | To | Cohort | Cycles | 6-month probabilities | Source | ||
|---|---|---|---|---|---|---|---|
| Base case | Minimum | Maximum | |||||
| Major cardiac event-free state | Myocardial infarction | BMS | First year | 2.14% | 1.83% | 2.48% | (7) |
| Following years | 1.32% | 1.16% | 1.48% | (7) | |||
| DES | First year | 1.40% | 0.82% | 2.19% | (7) | ||
| Following years | 1.02% | 0.61% | 1.57% | (7) | |||
| Major cardiac event-free state | Stent thrombosis | BMS | First year | 0.06% | 0.00% | 0.60% | (7) |
| Following years | 0.26% | 0.11% | 5.20% | (7) | |||
| DES | First year | 0.042% | 0.00% | 0.70% | (7) | ||
| Following years | 0.26% | 0.11% | 5.50% | (7) | |||
| Major cardiac event-free state | Second revascularisation | BMS | First year | 8.22% | 7.17% | 9.15% | (7) |
| Following years | 4.37% | 4.06% | 4.35% | (7) | |||
| DES | First year | 2.88% | 1.33% | 5.31% | (7) | ||
| Following years | 2.15% | 1.22% | 3.38% | (7) | |||
| Myocardial infarction | Death | − | − | 3.20% | 2.90% | 3.50% | (17) |
| Stent thrombosis | Death | − | − | 1.00% | 0.50% | 20.00% | Calibration |
| Second revascularisation | Death | − | − | 1.00% | 0.50% | 20.00% | Calibration |
| Stabilised post major cardiac event state | Death | − | − | 1.01% | 0.50% | 10.00% | (17) |
| Global death | BMS | First year | 0.12% | 0.00% | 0.78% | (7) | |
| Following years | 0.83% | 0.65% | 1.07% | (7) | |||
| DES | First year | 0.11% | 0.00% | 1.02% | (7) | ||
| Following years | 0.71% | 0.25% | 1.10% | (7) | |||
BMS, bare-metal stents; DES, drug-eluting stents.